Legal & General Group PLC Mirum Pharmaceuticals, Inc. Transaction History
Legal & General Group PLC
- $470 Billion
- Q3 2024
A detailed history of Legal & General Group PLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 39,431 shares of MIRM stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,431
Previous 39,431
-0.0%
Holding current value
$1.6 Million
Previous $1.54 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$267 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$182 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$140 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$131 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$125 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.49B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...